Navigation Links
deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2008 Financial Results
Date:7/31/2008

REYKJAVIK, Iceland, July 31 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (Nasdaq: DCGN) today announced that it will report its second quarter 2008 financial results in a press release to be issued on Wednesday, August 6, after the close of the market in New York. The company will host a live webcast of its conference call to discuss these results and recent operating highlights on Thursday, August 7, at 8am EDT/12 noon GMT/1pm British Summer Time.

The webcast can be accessed through the Investors page of deCODE's website, http://www.decode.com, or through http://www.earnings.com. Please log in to the webcast 15 minutes prior to the scheduled start of the call. The call will be archived for at least a week on each site. For those unable to listen to the webcast because of company firewall or other issues, a digitized audio replay will also be available by telephone from approximately 11:30am ET on Thursday, August 7 and for one week thereafter. The dial-in replay numbers are: 1 (800) 475-6701 in the U.S., and +1 (320) 365-3844 for those calling from outside the U.S. The access code is 955922.

Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events, to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form
'/>"/>

SOURCE deCODE genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
2. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results
3. deCODE genetics Announces Third Quarter 2007 Financial Results
4. deCODE Launches deCODEme(TM)
5. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
6. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
7. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
8. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
9. deCODE Genetics Announces Full-year 2007 Financial Results
10. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
11. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... Intarcia Therapeutics, Inc. deliv...S® continuous delivery of exenatide) program ...Annual Diabetes Technology Meeting in San Francisc...n/prnh/20050301/SFTU126LOGO ) ,, Continuous S...ers Plasma Glucose, HbA1c and Reduces Weight in a ...
(Date:11/5/2009)... 5 GenVec, Inc. (Nasdaq:... the third quarter ended September 30, 2009. GenVe...hare) for the three months ended September 30, 200...r share) in the comparable quarter of 2008. For th...et loss was $14.1 million ($0.15 per share), compa...
(Date:11/5/2009)...wswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulleti...er, President and CEO of Imagenetix, will be prese...RO Conference on Thursday, December 3rd, at 10:30 ...out LD MICRO ,, LD MICRO is a by-invitation onl...ued companies in the micro-cap space. Since 2002, ...
(Date:11/5/2009)...Newswire-FirstCall/ -- Transgenomic, Inc. (OTC Bul...ts for the quarter ended September 30, 2009. The C...bles that follow. ,, Third Quarter 2009 ,,....01 per share for the third quarter of 2009 as com... for the third quarter of 2008. ,, Net sales w...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...Pa., May 18 ViroPharma Incorporated (Nasdaq: VP...ional Organization for Rare Disorders (NORD) Annua...terase inhibitor (human)) to market for a rare and...E). , , HAE is a rare, severely debilitating, lif...ncy of C1 inhibitor, a human plasma protein. Patie...
...gazine Pays Tribute to America,s Top Research Scie...air of Prana,s Biotechnology Research & Develo...May 18 Dr. Rudy Tanzi, Prana Biotechnology,s (Nas...tor of the Genetics and Aging Research Unit at the...ses , will be featured in a six-page photo spread...
... Will be Reported from Phase 2 Studies Evaluating ...tal Cancer and Gastrointestinal Stromal Tumors (GI...ls, Inc. (Nasdaq: KERX ) today announced that fo...,s Akt-inhibitor for cancer, were accepted for pre...he 45th Annual Meeting of the American Society of ...
Other Biology Technology:ViroPharma Incorporated Honored by the National Organization for Rare Disorders 2ViroPharma Incorporated Honored by the National Organization for Rare Disorders 3ViroPharma Incorporated Honored by the National Organization for Rare Disorders 4ViroPharma Incorporated Honored by the National Organization for Rare Disorders 5ROCK STARS OF SCIENCE: Prana's Co-Founding Scientist, Rudy Tanzi Teams up with Star-Powered Cast in GQ Photoshoot 2ROCK STARS OF SCIENCE: Prana's Co-Founding Scientist, Rudy Tanzi Teams up with Star-Powered Cast in GQ Photoshoot 3Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 2Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 3Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 4
(Date:11/4/2009)...- Lowly bacteria, it turns out, hold the power to ... around the world clean up toxic waste on test sit...y RDX, were invented back in World War II and have...se high-energy compounds are often used to propel ...f TNT. , But with increased knowledge of their...
(Date:11/4/2009)....J., Oct. 20 Quest Diagn...ding provider of diagnostic testing, information a...ended September 30, 2009, income from continuing o...ed share, from $160 million, or $0.81 per diluted ...rd quarter results were reduced by a $0.03 per sha...
(Date:11/4/2009)...Calif., Oct. 23 GenVault Corporati...nagement for genomic discovery, medicine and ident...., GenVault,s President and CEO, will be presentin...n October 26th and 27th in La Jolla, CA. ,, Dur...verview of the company together with recent custom...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Prebiotics Add Heart Health Bone Health and Digestive Health Support to Research Proven Cancer Fighting Ability 58335 1Prebiotics Add Heart Health Bone Health and Digestive Health Support to Research Proven Cancer Fighting Ability 58335 2synergIT Presents at VMworld 2009 in San Francisco 58333 1synergIT Presents at VMworld 2009 in San Francisco 58333 2synergIT Presents at VMworld 2009 in San Francisco 58333 3RCRC Independent Review Board Announces DHHS Research Oversight 58331 1RCRC Independent Review Board Announces DHHS Research Oversight 58331 2
...ve hair-like protrusions with a sticky protein on ...ed, bungee cord-like structure of the protrusions ...gh fluid flow inside the body, researchers report ...hers at the University of Washington in Seattle an... the bacterium E. coli attaches to mucous membrane...
...h shows that a chemical compound found in many air...ther deodorizing products, may be harmful to the l...titute of Environmental Health Sciences (NIEHS), a...that exposure to a volatile organic compound (VOC)...odest reductions in lung function. , "Even a small...
... microorganisms manage to exist and even thrive in...ot springs? A team of scientists from the Weizmann...f. Avigdor Scherz, has found that a switch in just...can make a difference between functioning best at ...in extreme heat. The results of their research, wh...
Other Biology News:Tiny shock absorbers help bacteria stick around inside the body 2Chemical in many air fresheners may reduce lung function 2Chemical in many air fresheners may reduce lung function 3Bacteria beat the heat 2
...nal [6331] to Salmonella typhimurium The genus Sa...eae. The genus is composed of Gram-negative bacill...Salmonellae possess 3 major antigens; the "H" or f... antigen (part of the LPS moiety) and the "Vi" or ...
...W4 liquid handling system from Molecular Devices p...l in one instrument. The system handles a variety ...6-, 384- and 1536-welland is the first to handle 1...optimized to dispense from four different channels...
...sodium pyruvate, 50 mg/L streptomycin sulfate, 100...lcium chloride, and magnesium chloride. The use of...is generally attributed to early workers in the fi...f inorganic salts designed to maintain contractili...
Horizontal Laminar Flow Work Station from Terra Universal, Inc.
Biology Products: